14-Nov-2026 21:27:33

ANGGeneral news

ANG LIFESCIENCES Q2 FY27 ; CONS NET PROFIT DOWN 45.78% AT ₹266.05 L (YOY), DOWN 22.05% (QOQ)

REVENUE DOWN 27.05% AT ₹1877.18 L (YOY), DOWN 25.49% (QOQ) EBITDA DOWN 58.10% AT ₹(-339.14) L (YOY), DOWN 324.21% (QOQ) MARGINS AT -18.07% VS -8.66% (YOY), -3.02% (QOQ)

ANG Lifesciences India Ltd

Open attachment

← Back to feed